John Schieszer

 
 

Recent Articles

Vasectomy Reversal With Robotic Help

February 05, 2010

Single-surgeon series shows it can decrease operative time compared with traditional procedures.

Transplants Can Proceed Despite Substance Abuse

February 03, 2010

FT. LAUDERDALE, Fla.—Substance abuse by renal transplant recipients does not significantly affect graft and patient outcomes, according to new data presented at the American Society of Transplantation 10th Annual State of the Art Winter Symposium.

Obesity Need Not Rule Out Renal Transplants

February 03, 2010

FT. LAUDERDALE, Fla.— Elevated BMI in renal transplant recipients does not appear to impact early graft function and the risk of acute rejection, according to study findings presented here at the American Society of Transplantation 10th Annual State of the Art Winter Symposium.

Vaccine for Advanced Prostate Cancer Promising

January 28, 2010

Experimental immunotherapy prolonged survival in men with metastatic castration-resistant disease .

Hypertension, Fructose Intake Linked

January 22, 2010

Those who consume 74 grams or more of fructose daily are at higher risk than those who consume less.

SBRT Shows Promise for Localized Prostate Cancer

January 22, 2010

Hypofractionated stereotactic body radiotherapy achieves a good PSA response at a median of 24 months.

Albuminuria and Heart Disease Linked Only in White Diabetics

January 22, 2010

Albuminuria is strongly associated with the severity of calcified atherosclerotic plaque (CP) in white but not black individuals with type 2 diabetes, according to a new study.

Retrieved Sperm No Better Than Ejaculated Sperm

January 15, 2010

Men with severe oligoasthenospermia may be able to avoid testicular sperm retrieval, data suggest.

Adding Hormone Therapy to Radiotherapy Aids Survival

January 15, 2010

Patients with intermediate-risk prostate cancer benefit from androgen suppression plus radiotherapy.

Pre-RP Combo Could Improve PCa Outcomes

January 12, 2010

Radiation plus chemotherapy before surgery in men with high-risk prostate cancer boosts negative margin rate.